What Causes Vaginal Cancer? HPV, DES, and Other Risk Factors

Vaginal cancer is rare, which is good news. The bad news is that because it is rare, many people have never heard much about it until they are frantically typing questions into a search bar at 1:13 a.m. with one sock on and a half-finished cup of tea nearby. If that is you, take a breath. Here is the big picture: doctors do not always know the exact moment a normal vaginal cell decides to go rogue, but they do know the major risk factors that make vaginal cancer more likely.

The headline risk factor is persistent infection with high-risk human papillomavirus (HPV). But HPV is not the whole story. DES exposure before birth, older age, smoking, a weakened immune system, and a history of cervical precancer, cervical cancer, or vaginal precancer can all matter. In other words, vaginal cancer usually does not come from one dramatic villain twirling a mustache. It is more often the result of several biological troublemakers teaming up.

This guide breaks down what causes vaginal cancer, what “risk factor” really means, how HPV and DES fit into the picture, and what signs should send you to a doctor instead of to another round of doom-scrolling.

What causes vaginal cancer, exactly?

The most accurate answer is this: there is no single universal cause of vaginal cancer. Instead, there are known processes and risk factors that can increase the odds that cells in the vagina will develop abnormal changes and eventually become cancer.

That distinction matters. A risk factor is not a destiny stamp. Plenty of people with one or even several risk factors never develop vaginal cancer. And some people who are diagnosed have no obvious risk factor at all. Biology, as usual, refuses to keep things simple.

Most vaginal cancers begin in the thin, flat cells lining the vagina. This type is called squamous cell carcinoma, and it is by far the most common form. A smaller number begin in gland cells and are called adenocarcinomas. A rare subtype, clear cell adenocarcinoma, is the one classically linked to DES exposure in the womb.

HPV: the biggest risk factor in the room

Why HPV matters so much

When people ask what causes vaginal cancer, the answer most often starts with HPV. High-risk HPV types, especially HPV 16 and HPV 18, can infect cells and interfere with the body’s normal tumor-suppressing systems. In plain English, the virus can make it easier for abnormal cells to survive, multiply, and become dangerous over time.

That does not mean every HPV infection leads to cancer. In fact, most HPV infections clear on their own. The real concern is persistent high-risk HPV infection, meaning the virus sticks around long enough to keep irritating cells and pushing them in the wrong direction. That is when the risk rises.

HPV is also tied to vaginal intraepithelial neoplasia (VAIN), a precancerous condition in which cells in the vaginal lining look abnormal but are not yet invasive cancer. Not every case of VAIN progresses, but it is an important warning sign that the tissue has already entered a “something is off here” phase.

How HPV is connected to other gynecologic cancers

HPV gets a lot of attention for cervical cancer, and rightly so. But the same family of high-risk HPV strains can also contribute to cancers of the vagina, vulva, anus, penis, and parts of the throat. So while the cervix often hogs the spotlight in HPV conversations, the vagina can unfortunately end up in the same plotline.

This is one reason doctors pay close attention when someone has a history of abnormal Pap tests, cervical dysplasia, or cervical cancer. These conditions can signal long-term HPV exposure or persistent cell changes that may also affect nearby tissues.

DES exposure: a rare but important risk factor

What DES was

Diethylstilbestrol (DES) was a synthetic estrogen prescribed to some pregnant women between about 1940 and 1971 to try to prevent miscarriage and other pregnancy complications. Later, researchers found that people exposed to DES in the womb had a higher risk of developing a rare kind of vaginal and cervical cancer called clear cell adenocarcinoma.

This is one of the most well-known examples in women’s health of a medication causing consequences decades later. Not exactly the kind of family heirloom anyone wanted.

Who should think about DES today

If your mother or another parent took DES while pregnant, tell your healthcare provider, even if that happened long before disco, microwavable dinners, or modern diagnostic standards. DES exposure does not mean you will get vaginal cancer, but it does change your risk profile and can affect the kind of follow-up care your doctor recommends.

DES-related vaginal cancer is uncommon, but it matters because it is one of the clearest non-HPV links in this disease. When it does occur, it is most closely associated with clear cell adenocarcinoma, rather than the more common squamous cell type.

Other vaginal cancer risk factors doctors take seriously

Age

Vaginal cancer occurs mainly in older adults. The average age at diagnosis is typically in the late 60s. That does not mean younger people are immune, especially in DES-related cases, but age is one of the strongest overall risk factors. The longer we live, the more time cells have to accumulate damage and the more opportunities a persistent infection or chronic irritation has to cause trouble.

Smoking

Smoking is not just bad for your lungs; it is an equal-opportunity menace. Tobacco use is associated with a higher risk of several cancers, including vaginal cancer. One reason is that smoking appears to make it harder for the body to clear HPV infections. That means the virus can linger longer, and longer-lasting HPV is exactly what doctors do not want.

If there is a modifiable risk factor in this conversation that deserves a hard stare, smoking is absolutely one of them.

A weakened immune system

Anything that weakens the immune system can make it more difficult for the body to get rid of HPV and other abnormal cell changes. This includes conditions such as HIV infection and situations involving immunosuppressive medications, such as after an organ transplant.

The immune system is not perfect, but it does a lot of quiet housekeeping. When it is compromised, abnormal cells may be more likely to slip past security.

History of cervical precancer or cervical cancer

People who have had cervical dysplasia, cervical precancer, or cervical cancer may face a higher risk of vaginal cancer later. That is partly because these conditions often share HPV as a common thread. It does not mean vaginal cancer is inevitable. It does mean follow-up care matters.

Vaginal precancer and vaginal adenosis

VAIN is an important precursor lesion because it reflects abnormal cells in the vaginal lining before invasive cancer develops. Another condition, vaginal adenosis, is more strongly associated with DES exposure and may also be part of the story in some cases. These conditions are not interchangeable, but both signal tissue changes that deserve medical attention.

Does a Pap test screen for vaginal cancer?

Here is a common point of confusion: the Pap test is designed to screen for cervical cancer, not vaginal cancer. There is currently no routine screening test for vaginal cancer in people without symptoms.

That said, vaginal cancer is sometimes found during a pelvic exam or during follow-up for abnormal cervical screening results. So while a Pap test is not a true vaginal cancer screening tool, gynecologic care can still help uncover suspicious changes before they become a larger problem.

This is why people with higher risk, especially those with DES exposure or a history of cervical abnormalities, should stay current with medical follow-up. The goal is not panic. The goal is not letting important clues drift by unnoticed because “it was probably nothing.” Sometimes it is nothing. Sometimes it deserves a closer look.

Symptoms that should not be ignored

Early vaginal cancer may cause no symptoms at all. When symptoms do happen, they can overlap with much more common conditions like infection, irritation, polyps, menopause-related changes, or benign bleeding. That is why symptoms should be checked, not self-awarded a diagnosis.

Possible warning signs include:

• Abnormal vaginal bleeding, especially after sex or after menopause
• Watery, bloody, or unusual vaginal discharge
• Pain during sex
• A lump or mass in the vagina
• Pelvic pain or pressure
• Painful urination or constipation in more advanced cases

The key phrase is not normal for you. If something changes and stays changed, it deserves professional attention. No gold stars are awarded for trying to out-stubborn a symptom.

Can vaginal cancer be prevented?

You cannot control every risk factor, but you can reduce the odds.

1. Get the HPV vaccine if it is appropriate for you

The HPV vaccine protects against the strains most often linked to cervical, vaginal, and vulvar cancers. It works best before exposure to HPV, but vaccination recommendations can still apply into young adulthood and, in some cases, later depending on age and individual circumstances.

2. Do not smoke

Quitting smoking supports the immune system and reduces cancer risk across the board. Not glamorous, not trendy, but deeply effective.

3. Follow up on abnormal cervical tests

If you have an abnormal Pap test, positive HPV test, cervical dysplasia, or a history of cervical cancer, do not ghost your follow-up appointment. Persistent HPV and abnormal cell changes are exactly the kinds of issues that benefit from timely monitoring and treatment.

4. Know your DES history

If there is any chance you were exposed to DES before birth, bring it up with your clinician. That information can change how your care is managed.

5. Pay attention to symptoms

Since there is no routine screening test for asymptomatic vaginal cancer, awareness matters. Bleeding after menopause, bleeding after sex, unusual discharge, or a vaginal mass should not sit on the “maybe later” list.

What this diagnosis usually means in real life

Because vaginal cancer is uncommon, many people diagnosed with it say the first emotion is not fear but confusion. They may have heard plenty about breast cancer, cervical cancer, or ovarian cancer, but very little about vaginal cancer. Symptoms are often subtle at first. A person may assume bleeding is hormonal, discharge is infectious, or pelvic discomfort is just one more annoying plot twist of aging. The rarity of the disease can delay recognition, which is one reason awareness matters so much.

Doctors also look closely at the full context: age, HPV history, immune status, smoking history, prior cervical treatment, and possible DES exposure. Vaginal cancer is not usually a mystery solved by a single clue. It is more like a case built from several small details that only make sense when viewed together.

Experiences related to vaginal cancer risk: what people often go through

The experiences below are composite examples based on common clinical patterns and patient concerns. They are not individual medical stories, but they reflect the kinds of real-life situations that often surround questions about vaginal cancer, HPV, DES, and other risk factors.

Experience 1: “I thought it was just menopause.”

A woman in her late 60s notices light spotting after sex and assumes dryness or menopause is to blame. She waits. Then she notices watery discharge and a dull pelvic ache that keeps hanging around like an unwanted houseguest. Her pelvic exam leads to further testing, and doctors find vaginal cancer. This experience is common in one important way: the first symptoms are easy to dismiss. Many people do not jump straight from “spotting” to “possible cancer,” and honestly, who would? But postmenopausal bleeding always deserves evaluation, even when the explanation turns out to be something much less serious.

Experience 2: “I had years of abnormal HPV and Pap results.”

Another person has a long history of high-risk HPV and several abnormal cervical screening results. She has already gone through colposcopy, biopsies, maybe even treatment for cervical dysplasia, and she is exhausted by the whole process. When another abnormality shows up, her first reaction is frustration more than fear. This pattern highlights an important truth: persistent HPV can affect more than one nearby area over time. For people with repeated abnormal cervical findings, consistent follow-up is not overkill. It is smart surveillance.

Experience 3: “I found out I was exposed to DES before birth.”

Sometimes a patient only learns about DES exposure decades later after a conversation with an older parent or a review of family medical history. Suddenly, random facts from another era become medically relevant. She may feel angry, blindsided, or just deeply weirded out that a drug used before she was born still matters now. That reaction is understandable. DES exposure is a real, specific, long-term risk factor, and sharing that information with a healthcare provider can change the level of vigilance and the kind of evaluation recommended.

Experience 4: “I was told HPV is common, so I stopped worrying.”

HPV is common, and most infections clear. But some people hear that and conclude every HPV result is basically meaningless. Then years later, a persistent infection or a precancerous change changes the conversation. The experience here is less about guilt and more about nuance. Common does not mean harmless in every case. The right takeaway is not panic; it is follow-through.

Experience 5: “I almost ignored the symptom because it was embarrassing.”

Many people delay care because talking about vaginal symptoms can feel awkward. There is still a lot of silence around gynecologic symptoms, especially those involving sex, discharge, bleeding, or the vagina itself. But cancer does not get less real because a symptom feels awkward to say out loud. In practice, one of the most powerful habits is simply reporting what has changed without trying to edit it into something more polite.

Final thoughts

If you are looking for one simple answer to what causes vaginal cancer, here it is: the strongest known driver is persistent high-risk HPV infection, but vaginal cancer can also be linked to DES exposure before birth, older age, smoking, a weakened immune system, and a history of cervical or vaginal precancer.

Just as important, risk is not fate. Many people with risk factors never develop vaginal cancer, and some people diagnosed did not know they were at risk at all. The smartest response is not fear. It is awareness, prevention, and timely follow-up. Get recommended HPV vaccination if appropriate. Stay on top of cervical screening and follow-up care. Tell your doctor about DES exposure if it may apply. And do not ignore bleeding, discharge, pain, or a lump just because it is easier to hope it disappears on its own.

Your body does not need perfection. It just needs your attention.